Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets

Journal of Infection

Volumn 69, Issue 6, 2014, Pages 581-589

  Baumann, Ralf ^a,b   Kaempfer, Susanne ^b   Chegou, Novel N ^a   Oehlmann, Wulf ^b   Loxton, André G ^a   Kaufmann, Stefan H E ^c   van Helden, Paul D ^a   Black, Gillian F ^a   Singh, Mahavir ^b   Walzl, Gerhard ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b LIONEX DIAGNOSTICS AND THERAPEUTICS GMBH   (Germany)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Ig classes; Latent Mycobacterium tuberculosis infection; Serology; Tuberculosis; Tuberculosis endemic setting

Indexed keywords

ALANINE AND PROLINE RICH SECRETED PROTEIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 16.3; HEAT SHOCK PROTEIN 20; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LIPOARABINOMANNAN; MYCOBACTERIUM ANTIGEN; PE35 ANTIGEN; PEROXIDASE; THIOL PEROXIDASE; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN CLASS; LIPOPOLYSACCHARIDE; MYCOBACTERIUM TUBERCULOSIS ANTIGENS;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MALE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TUBERCULIN TEST; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED; MOLECULAR CLONING; MULTIVARIATE ANALYSIS; SEROLOGY; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; LATENT TUBERCULOSIS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84922818453     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.05.014     Document Type: Article

References (46)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
2. Boehme C.C., Nabeta P., Hillemann D., Nicol M.P., Shenai S., Krapp F., et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
3. Trébucq A., Enarson D.A., Chiang C.Y., van Deun A., Harries A.D., Boillot F., et al. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?. Int J Tuberc Lung Dis 2011, 15:1567-1572.
4. Sallusto F., Lenig D., Förster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
5. Walzl G., Ronacher K., Hanekom W., Scriba T.J., Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol 2011, 11:343-354.
6. Ewer K., Millington K.A., Deeks J.J., Alvarez L., Bryant G., Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006, 174:831-839.
7. Chiappini E., Della Bella C., Bonsignori F., Sollai S., Amedei A., Galli L., et al. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis. PLoS One 2012, 7:e46041.
8. Petruccioli E., Petrone L., Vanini V., Sampaolesi A., Gualano G., Girardi E., et al. IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013, 66:475-486.
9. Abebe F., Holm-Hansen C., Wiker H.G., Bjune G. Progress in serodiagnosis of Mycobacterium tuberculosis infection. Scand J Immunol 2007, 66:176-191.
10. Chan E.D., Reves R., Belisle J.T., Brennan P.J., Hahn W.E. Diagnosis of tuberculosis by a visually detectable immunoassay for lipoarabinomannan. Am J Respir Crit Care Med 2000, 161:1713-1719.
11. Daniel T.M., Debanne S.M. The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis 1987, 135:1137-1151.
12. Steingart K.R., Flores L.L., Dendukuri N., Schiller I., Laal S., Ramsay A., et al. Commercial serological tests for the diagnosis of active pulmonary and extrapulmonary tuberculosis: an updated systematic review and meta-analysis. PLoS Med 2011, 8:e1001062.
13. Bothamley G.H. Serological diagnosis of tuberculosis. Eur Respir J Suppl 1995, 20:676s-688s.
14. Lyashchenko K., Colangeli R., Houde M., Al Jahdali H., Menzies D., Gennaro M.L. Heterogeneous antibody responses in tuberculosis. Infect Immun 1998, 66:3936-3940.
15. Reed M.B., Gagneux S., Deriemer K., Small P.M., Barry C.E. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 2007, 189:2583-2589.
16. Abebe F., Bjune G. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by Bacille Calmette-Guérin (BCG) vaccines: is there a link?. Clin Exp Immunol 2006, 145:389-397.
17. Hoff S.T., Abebe M., Ravn P., Range N., Malenganisho W., Rodriques D.S., et al. Evaluation of Mycobacterium tuberculosis-specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis 2007, 45:575-582.
18. Rasolofo V., Chanteau S. Field evaluation of rapid tests for tuberculosis diagnosis. J Clin Microbiol 1999, 37:4201.
19. Laal S., Samanich K.M., Sonnenberg M.G., Zolla-Pazner S., Phadtare J.M., Belisle J.T. Human humoral responses to antigens of Mycobacterium tuberculosis: immunodominance of high-molecular-mass antigens. Clin Diagn Lab Immunol 1997, 4:49-56.
20. Rosenkrands I., Aagaard C., Weldingh K., Brock I., Dziegiel M.H., Singh M., et al. Identification of Rv0222 from RD4 as a novel serodiagnostic target for tuberculosis. Tuberculosis (Edinb) 2008, 88:335-343.
21. Hastie T.J., Tibshirani R.J., Friedman J. The elements of statistical learning: data mining, inference, and prediction 2008, Springer, New York, NY. 10 ed.
22. Ferrara G., Losi M., D'Amico R., Roversi P., Piro R., Meacci M., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006, 367:1328-1334.
23. Arend S.M., Thijsen S.F.T., Leyten E.M.S., Bouwman J.J.M., Franken W.P.J., Koster B.F.P.J., et al. Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007, 175:618-627.
24. Hill P.C., Brookes R.H., Adetifa I.M.O., Fox A., Jackson-Sillah D., Lugos M.D., et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006, 117:1542-1548.
25. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000, 49:1-51.
26. Fine P.E., Bruce J., Ponnighaus J.M., Nkhosa P., Harawa A., Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999, 3:962-975.
27. Roberts T., Beyers N., Aguirre A., Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J Infect Dis 2007, 195:870-878.
28. Black G.F., Thiel B.A., Ota M.O., Parida S.K., Adegbola R., Boom W.H., et al. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol 2009, 16:1203-1212.
29. Gounder C., de Queiroz Mello FC., Conde M.B., Bishai W.R., Kritski A.L., Chaisson R.E., et al. Field evaluation of a rapid immunochromatographic test for tuberculosis. J Clin Microbiol 2002, 40:1989-1993.
30. Conde M.B., Suffys P., Lapa E Silva J.R., Kritski A.L., Dorman S.E. Immunoglobulin A (IgA) and IgG immune responses against P-90 antigen for diagnosis of pulmonary tuberculosis and screening for Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 2004, 11:94-97.
31. Kunnath-Velayudhan S., Davidow A.L., Wang H., Molina D.M., Huynh V.T., Salamon H., et al. Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients. J Infect Dis 2012, 206:697-705.
32. Mishra A.K., Driessen N.N., Appelmelk B.J., Besra G.S. Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev 2011, 35:1126-1157.
33. Sada E., Brennan P.J., Herrera T., Torres M. Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis. J Clin Microbiol 1990, 28:2587-2590.
34. Laqueyrerie A., Militzer P., Romain F., Eiglmeier K., Cole S., Marchal G. Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immun 1995, 63:4003-4010.
35. Samanich K.M., Keen M.A., Vissa V.D., Harder J.D., Spencer J.S., Belisle J.T., et al. Serodiagnostic potential of culture filtrate antigens of Mycobacterium tuberculosis. Clin Diagn Lab Immunol 2000, 7:662-668.
36. Samanich K.M., Belisle J.T., Sonnenberg M.G., Keen M.A., Zolla-Pazner S., Laal S. Delineation of human antibody responses to culture filtrate antigens of Mycobacterium tuberculosis. J Infect Dis 1998, 178:1534-1538.
37. Brusasca P.N., Colangeli R., Lyashchenko K.P., Zhao X., Vogelstein M., Spencer J.S., et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol 2001, 54:448-452.
38. Mukherjee P., Dutta M., Datta P., Dasgupta A., Pradhan R., Pradhan M., et al. The RD1-encoded antigen Rv3872 of Mycobacterium tuberculosis as a potential candidate for serodiagnosis of tuberculosis. Clin Microbiol Infect 2007, 13:146-152.
39. Davidow A., Kanaujia G.V., Shi L., Kaviar J., Guo X., Sung N., et al. Antibody profiles characteristic of Mycobacterium tuberculosis infection state. Infect Immun 2005, 73:6846-6851.
40. Zhang G., Zhang L., Zhang M., Pan L., Wang F., Huang J., et al. Screening and assessing 11 Mycobacterium tuberculosis proteins as potential serodiagnostical markers for discriminating TB patients from BCG vaccinees. Genomics Proteomics Bioinformatics 2009, 7:107-115.
41. Stewart G.R., Wernisch L., Stabler R., Mangan J.A., Hinds J., Laing K.G., et al. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology (Reading, Engl.) 2002, 148:3129-3138.
42. Wilkinson K.A., Stewart G.R., Newton S.M., Vordermeier H.M., Wain J.R., Murphy H.N., et al. Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2. J Immunol 2005, 174:4237-4243.
43. Rho B., Hung L., Holton J.M., Vigil D., Kim S., Park M.S., et al. Functional and structural characterization of a thiol peroxidase from Mycobacterium tuberculosis. J Mol Biol 2006, 361:850-863.
44. Weldingh K., Rosenkrands I., Jacobsen S., Rasmussen P.B., Elhay M.J., Andersen P. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect Immun 1998, 66:3492-3500.
45. Kunnath-Velayudhan S., Salamon H., Wang H., Davidow A.L., Molina D.M., Huynh V.T., et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A 2010, 107:14703-14708.
46. Julián E., Matas L., Ausina V., Luquin M. Detection of lipoarabinomannan antibodies in patients with newly acquired tuberculosis and patients with relapse tuberculosis. J Clin Microbiol 1997, 35:2663-2664.